Adult Congenital Heart Disease Program at UC San Diego Health

San Diego, CA — (858) 246-3271

There are board certified ACHD physicians at this location.

Sulpizio Cardiovascular Center
9434 Medical Center Drive
San Diego, CA 92093
USA

(858) 246-3271
(858) 246-3271
(858) 246-3271
ACHD@ucsd.edu
Visit Now
Yes

Affiliations

UC San Diego Health Suplizio Cardiovascular Center
Adult Hospital
Rady Children's Hospital
Pediatric Hospital
University of California San Diego

Clinic Staffing

Medical Director

Laith Alshawabkeh, MD, MSCI Professional ACHA Member
ACHD, IM, IM Card
4
100%

Medical Co-Director

Howaida El-Said, MD, PhD Professional ACHA Member
ACHD, Peds, Ped Card
10
20%

Administrative Program Director/Manager

Halle Siepman
Administrative Program Coordinator

1 Additional Cardiologists attend Clinic

Jose Sepulveda, MD
IM Card, Peds, Ped Card

Nursing & Other Staff

1
Deborah Raleigh Nurse Practitioner
Maria Moceri Casas, RN, BSN, CHPN
Alicia Gormican Manager, Cardiovascular Operations

Care Setting

4
UC San Diego Health Sulpizio Cardiovascular Center
Yes
Yes
Adult Hospital
Adult Hospital
Adult Hospital
Yes
Yes - at age 16
Yes, weekly
Yes

Training & Research

Yes
Formal ACHD rotation for general cardiology fellows (in Adult) Individualized long-term mentoring (or informal ACHD fellowship)
Yes
2018
Data valid at 2018

Director's Description

The Adult Congenital Heart Disease Program at UC San Diego Health is a joint collaboration with Rady Children’s Hospital – San Diego.

Our program is located in Sulpizio Cardiovascular Center at the La Jolla campus and is the first and only program of its kind in San Diego to offer a multidisciplinary approach to care of adults with congenital heart disease. The program prides itself on ease of referral and communication with referring providers. The program is structured around patient centered care to accommodate the needs for the patients and their families. We offer combined Pregnancy and Heart Disease services and close collaboration with high-risk obstetrics, in addition to management of end-stage heart failure and transplantation.